Download
https://www.ndtvprofit.com/business/diagnostic-chains-the-pandemics-big-bet-is-proving-to-be-a-dud?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Despite the selloff, diagnostic chain stocks are still relatively pricey compared to pharma and healthcare companies.
Share